Neurodegeneration with brain iron accumulation, type 1 is characterized by α-, β-, and γ-synuclein neuropathology

American Journal of Pathology

Volumn 157, Issue 2, 2000, Pages 361-368

  Galvin, James E ^a,b   Giasson, Benoit ^b   Hurtig, Howard I ^c   Lee, Virginia M Y ^b   Trojanowski, John Q ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b Center for Neurodegenerative Disease Research   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; BETA SYNUCLEIN; BRAIN PROTEIN; GAMMA SYNUCLEIN; IRON; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CASE REPORT; CEREBELLAR ATAXIA; CHILD; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DEGENERATIVE DISEASE; HALLERVORDEN SPATZ DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROAXONAL DYSTROPHY; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0033897735     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64548-8     Document Type: Article

References (42)

1. The nosology of Hallervorden-Spatz disease
2. Hallervorden-Spatz syndrome
3. Late onset Hallervorden-Spatz disease presenting as familial parkinsonism
4. Homozygosity mapping of Hallervorden-Spatz syndrome to chromosome 20p12.3-p13
5. Acanthosytosis, retinitis pigmentosa, pallidal degeneration. Report of two cases without serum lipid abnormalities
6. Neuroaxonal dystrophy combined with diffuse Lewy body disease in a young adult
7. Hallervorden-Spatz syndrome and brain iron metabolism
8. Optic atrophy as the first symptom in Hallervorden-Spatz syndrome
9. Clinicopathologic correlation and pathogenesis of ocular and central nervous system manifestations in Hallervorden-Spatz syndrome
10. Superoxide dismutase-like immunoreactivity in spheroids in Haller vorden-Spatz disease
11. Hallervorden-Spatz disease: MR and pathologic findings
12. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein
13. Adult onset Hallervorden-Spatz disease with neurofibrillary pathology
14. Myopathic involvement in two cases of Hallervorden-Spatz disease
15. Liver and pituitary abnormalities in Haller vorden-Spatz disease
16. Osmiophilic deposits in cytosomes in Hallervorden-Spatz syndrome
17. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple systems atrophy brains contain insoluble α-synuclein
18. Widespread occurrence of α-synucelin/NACP-immunoreactive neuronal inclusions in juvenile and adult-onset Hallervorden-Spatz disease with Lewy bodies
19. Alzheimer's amyloid precursor protein accumulates within axonal swelling in human brain lesions
20. Alpha-synuclein immunoreactivity is present in axonal swellings in neuroaxonal dystrophy and acute traumatic brain injury
21. Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and Lewy body pathology
22. Alzheimer neurofibrillary tangles in diseases other than senile and presenile dementia
23. Monoclonal antibodies to purified cortical Lewy bodies recognize the mid-size neurofilament subunit
24. Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains α-, β- and γ-synuclein
25. Epitope map of neurofilament protein domains in cortical and peripheral nervous system Lewy bodies
26. Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain
27. Epitope mapping of LB509, a monoclonal antibody directed against human α-synuclein
28. A panel of epitope-specific antibodies detect protein domains distributed throughout human α-synuclein in Lewy bodies of Parkinson's disease
29. Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17
30. Expression patterns of β-amyloid precursor protein (β-APP) in neural and non-neural human tissues from Alzheimer's disease and control subjects
31. Plaque associated neuronal proteins: A recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain
32. Lewy bodies contain altered α-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes
33. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease
34. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease
35. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
36. Antibodies to α-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease
37. Synucleins in synaptic plasticity and neurodegenerative disorders
38. Genetic classification of primary neurode generative disease
39. Fatal attractions: Abnormal protein aggregation and neuron death in Parkinson's disease and Lewy body dementia
40. Widespread alterations of α-synuclein in multiple system atrophy